Cell therapies for inflammatory bowel diseases

Expert Review of Gastroenterology and Hepatology

Volumn 3, Issue 4, 2009, Pages 321-324

  Salas, Azucena ^a   Ricart, Elena ^a   Panés, Julián ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 6;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL THERAPY; CROHN DISEASE; CYTOKINE PRODUCTION; EDITORIAL; ENTERITIS; HUMAN; IMMUNOTHERAPY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ADOPTIVE TRANSFER; ANIMALS; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 70049097211     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.09.26     Document Type: Editorial

References (23)

1. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54(2), 237-241 (2005).
2. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review, mesenchymal stem cells, their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11), 2739-2749 (2007).
3. Kapoor S, Wilson AG, Sharrack B et al. Haemopoietic stem cell transplantation -an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 12(3), 179-191 (2007).
4. Marmont AM. Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems. Haematologica 86(4), 337-345 (2001).
5. Burt RK, Loh Y, Pearce W et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299(8), 925-936 (2008).
6. Fortun PJ, Hawkey CJ. The role of stem cell transplantation in inflammatory bowel disease. Autoimmunity 41(8), 654-659 (2008).
7. Oyama Y, Craig RM, Traynor AE et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128(3), 552-563 (2005).
8. + cell selection in refractory Crohn's disease. Gut 57(2), 211-217 (2008).
9. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8(9), 726-736 (2008).
10. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58(7), 929-939 (2009).
11. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136(3), 978-989 (2009).
12. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A Phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 48(7), 1416-1423 (2005).
13. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8(2), 191-197 (2007).
14. Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 105(49), 19396-19401 (2008).
15. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with Type 1 diabetes. Diabetes 54(1), 92-99 (2005).
16. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178(4), 2579-2588 (2007).
17. + regulatory T cells. J. Immunol. 170(8), 3939-3943 (2003).
18. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212(1), 217-237 (2006).
19. + regulatory T cells allows for their purification from expansion cultures. Blood 113(21), 5125-5133 (2009).
20. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197(4), 451-460 (2003).
21. + T cell-mediated suppression by dendritic cells. Science 299(5609), 1033-1036 (2003).
22. Suciu-Foca N, Berloco P, Cortesini R. Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases. Hum. Immunol. 70(5), 277-280 (2009).
23. Gonzalez-Rey E, Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 131(6), 1799-1811 (2006).